{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T17:58:42Z","timestamp":1791136722676,"version":"4.1.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,12,1]]},"DOI":"10.1215\/15228517-2008-062","type":"journal-article","created":{"date-parts":[[2008,8,14]],"date-time":"2008-08-14T21:40:18Z","timestamp":1218750018000},"page":"1010-1018","source":"Crossref","is-referenced-by-count":111,"title":["Prognostic factors and outcomes in patients with leptomeningeal melanomatosis"],"prefix":"10.1093","volume":"10","author":[{"given":"Laura","family":"Harstad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth R.","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morris D.","family":"Groves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2008,12,1]]},"reference":[{"key":"key\n\t\t\t\t20171013035730_REF1","doi-asserted-by":"crossref","unstructured":"Groves MD. Leptomeningeal carcinomatosis: diagnosis and management. In: Sawaya R, ed. Intracranial Metastases: Current Management Strategies. Malden, MA: BlackwellFutura; 2004: 309-330.","DOI":"10.1002\/9780470753064.ch18"},{"key":"key\n\t\t\t\t20171013035730_REF2","doi-asserted-by":"crossref","unstructured":"Balm M, Hammack J. Leptomeningeal carcinomatosis: presenting features and prognostic factors. Arch Neurol. 1996;53: 626-632.","DOI":"10.1001\/archneur.1996.00550070064013"},{"key":"key\n\t\t\t\t20171013035730_REF3","doi-asserted-by":"crossref","unstructured":"Yap HY, Yap BS, Rasmussen S, et al. Treatment for meningeal carcinomatosis in breast cancer. Cancer. 1982;15: 219-222.","DOI":"10.1002\/1097-0142(19820715)50:2<219::AID-CNCR2820500209>3.0.CO;2-7"},{"key":"key\n\t\t\t\t20171013035730_REF4","doi-asserted-by":"crossref","unstructured":"Rosen ST, Aisner J, Makuch RW, et al. Carcinomatous leptomeningitis in small cell lung cancer: a clinicopathologic review for the National Cancer Institute experience. Medicine (Baltimore). 1982;61: 45-53.","DOI":"10.1097\/00005792-198201000-00005"},{"key":"key\n\t\t\t\t20171013035730_REF5","doi-asserted-by":"crossref","unstructured":"Amer MH, Al-Sarraf M, Baker LH, et al. Malignant melanoma and central nervous system metastasis: incidence, diagnosis, treatment, and survival. Cancer. 1978;42: 660-668.","DOI":"10.1002\/1097-0142(197808)42:2<660::AID-CNCR2820420237>3.0.CO;2-E"},{"key":"key\n\t\t\t\t20171013035730_REF6","doi-asserted-by":"crossref","unstructured":"Wasserstrom WR, Glass JP, Posner JB. Diagnosis and treatment of leptomeningeal metastasis from solid tumors: experience from 90 patients. Cancer. 1982;49: 759-772.","DOI":"10.1002\/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7"},{"key":"key\n\t\t\t\t20171013035730_REF7","doi-asserted-by":"crossref","unstructured":"Byrne TN, Cascino TL, Posner JB. brain metastasis from melanoma. J Neurooncol. 1983;1: 313-317.","DOI":"10.1007\/BF00165714"},{"key":"key\n\t\t\t\t20171013035730_REF8","unstructured":"Posner JB, Chernik NL. Intracranial metastases from systemic cancer. Adv Neurol. 1978;19: 575-587."},{"key":"key\n\t\t\t\t20171013035730_REF9","unstructured":"Glantz MJ, Jaeckle KA, Chamberlain MC, et al. A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors. Clin Cancer Res. 1999;5: 3394-3402."},{"key":"key\n\t\t\t\t20171013035730_","doi-asserted-by":"crossref","unstructured":"Chamberlain MC, Tsao-Wei D, Groshen S. Neoplastic meningitis-related encephalopathy: prognostic significance. Neurology. 2004;63: 2159-2161.","DOI":"10.1016\/0090-3019(91)90079-O"},{"key":"key\n\t\t\t\t20171013035730_","doi-asserted-by":"crossref","unstructured":"Sause TW, Crowley J, Eyre HJ, et al. Whole brain irradiation and intrathecal methotrexate in the treatment of solid tumor leptomeningeal metastasis: a Southwest Oncology Group Study. J Neurooncol. 1988;6: 107-112.","DOI":"10.1016\/0090-3019(91)90079-O"},{"key":"key\n\t\t\t\t20171013035730_","doi-asserted-by":"crossref","unstructured":"Hitchins RM, Bell DR, Woods RL, et al. A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis. J Clin Oncol. 1987;5: 1655-1662.","DOI":"10.1016\/0090-3019(91)90079-O"},{"key":"key\n\t\t\t\t20171013035730_","doi-asserted-by":"crossref","unstructured":"Little JR, Dale AJD, Okazaki H. Meningeal carcinomatosis: clinical manifestations. Arch Neurol. 1974;30: 138-143.","DOI":"10.1016\/0090-3019(91)90079-O"},{"key":"key\n\t\t\t\t20171013035730_","doi-asserted-by":"crossref","unstructured":"Chamberlain MC, Kormanik PA. Prognostic significance of coexistent bulky metastatic central nervous system disease in patients with leptomeningeal metastases. Arch Neurol. 1997;54: 1364-1368.","DOI":"10.1016\/0090-3019(91)90079-O"},{"key":"key\n\t\t\t\t20171013035730_REF15","doi-asserted-by":"crossref","unstructured":"Clamon G, Doebbeling B. Meningeal carcinomatosis from breast cancer: spinal cord versus brain involvement. Br Cancer Res Treat.1987;5: 1955-1662.","DOI":"10.1007\/BF01806382"},{"key":"key\n\t\t\t\t20171013035730_","doi-asserted-by":"crossref","unstructured":"Jayson GC, Howell A, Harris M, et al. Carcinomatous meningitis in patients with breast cancer: an aggressive disease variant. Cancer. 1994;74: 3135-3141.","DOI":"10.1016\/0090-3019(91)90079-O"},{"key":"key\n\t\t\t\t20171013035730_REF17","doi-asserted-by":"crossref","unstructured":"Boogerd W, Hart AAM, van der Sande JJ, et al. Meningeal carcinomatosis in breast cancer: prognostic factors and influence of treatment. Cancer. 1991;67: 1685-1695.","DOI":"10.1002\/1097-0142(19910315)67:6<1685::AID-CNCR2820670635>3.0.CO;2-M"},{"key":"key\n\t\t\t\t20171013035730_REF18","doi-asserted-by":"crossref","unstructured":"Fizazi K, Asselain B, Vincent-Salomon A, et al. Meningeal carcinomatosis in patients with breast carcinoma: clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen. Cancer. 1998;77: 1315-1323.","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1315::AID-CNCR14>3.0.CO;2-4"},{"key":"key\n\t\t\t\t20171013035730_REF19","doi-asserted-by":"crossref","unstructured":"Katz KA, Jonasch E, Hodi FS, et al. Melanoma of unknown primary: experience at Massachusetts General Hospital and Dana-Farber Cancer Institute. Melanoma Res. 2005;15: 77-82.","DOI":"10.1097\/00008390-200502000-00013"},{"key":"key\n\t\t\t\t20171013035730_","doi-asserted-by":"crossref","unstructured":"Carella RJ, Gelber R, Hendrickson F, et al. Value of radiation therapy in the management of patients with cerebral metastases from malignant melanoma. Cancer. 1980;45: 679-683.","DOI":"10.1016\/0090-3019(91)90079-O"},{"key":"key\n\t\t\t\t20171013035730_","doi-asserted-by":"crossref","unstructured":"McKay MJ, Peters LJ, Ainslie J. Radiotherapy for distant metastasis and clinical radiobiology of melanoma. In: Balch CM, Houghton AN, Sober AJ, Soong S, eds. Cutaneous melanoma. 4th ed. St. Louis, MO: Quality Medical Publishing; 2003: 573-586.","DOI":"10.1016\/0090-3019(91)90079-O"},{"key":"key\n\t\t\t\t20171013035730_","doi-asserted-by":"crossref","unstructured":"Grossman SA, Finkelstein DM, Ruckdeschel DL, et al. Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. J Clin Oncol. 1993;11: 561-569.","DOI":"10.1016\/0090-3019(91)90079-O"},{"key":"key\n\t\t\t\t20171013035730_REF23","doi-asserted-by":"crossref","unstructured":"Cokgor I, Akabani G, Friedman HS, et al. Long term response in a patient with neoplastic meningitis secondary to melanoma treated with 131I-radiolabeled antichondroitin proteoglycan sulfate mel-14 F(ab')2: a case study. Cancer. 2001;91: 1809-1813.","DOI":"10.1002\/1097-0142(20010501)91:9<1809::AID-CNCR1200>3.0.CO;2-L"},{"key":"key\n\t\t\t\t20171013035730_REF24","doi-asserted-by":"crossref","unstructured":"Herrlinger U, Weller M, Schabet M. New aspects of immunotherapy of leptomeningeal metastasis. J Neurooncol. 1998;38: 233-239.","DOI":"10.1023\/A:1005948722912"},{"key":"key\n\t\t\t\t20171013035730_","doi-asserted-by":"crossref","unstructured":"Moser RP, Bruner JM, Grimm EA. biologic therapy for brain tumors. Cancer Bull. 1991;43: 117-126.","DOI":"10.1016\/0090-3019(91)90079-O"},{"key":"key\n\t\t\t\t20171013035730_","doi-asserted-by":"crossref","unstructured":"Papadopoulos NE, Moser RP, Grimm E, et al. Intrathecal use of recombinant interleukin-2 (rIL-2) in the treatment of leptomeningeal disease (LMD) from metastatic melanoma [abstract]. Proc Annu Meet Am Soc Clin Oncol. 1995;14: A1307.","DOI":"10.1016\/0090-3019(91)90079-O"},{"key":"key\n\t\t\t\t20171013035730_","doi-asserted-by":"crossref","unstructured":"Meyers SA, Obbens EAMT, Schiebel RS, et al. Neurotoxicity of intraventricularly administered alpha-interferon for leptomeningeal disease. Cancer. 1991;68: 88-92.","DOI":"10.1016\/0090-3019(91)90079-O"},{"key":"key\n\t\t\t\t20171013035730_","doi-asserted-by":"crossref","unstructured":"Heimans JJ, Wagstaff J, Schreuder WO, et al. Treatment of leptomeningeal carcinomatosis with continuous intraventricular infusion of recombinant interleukin-2. Surg Neurol. 1991;35: 244-247.","DOI":"10.1016\/0090-3019(91)90079-O"},{"key":"key\n\t\t\t\t20171013035730_REF29","doi-asserted-by":"crossref","unstructured":"Samlowski WE, Park KJ, Galinsky RE, et al. Intrathecal administration for interleukin-2 for meningeal carcinomatosis due to malignant melanoma: sequential evaluation of intracranial pressure, cerebrospinal fluid cytology, and cytokine induction. J Immunother. 1993;13: 49-54.","DOI":"10.1097\/00002371-199301000-00007"},{"key":"key\n\t\t\t\t20171013035730_REF30","unstructured":"Balch CM, Atkins MB, Sober AJ. Cutaneous melanoma. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice Of Oncology. 7th ed. New York: Lippincott Williams & Wilkins; 2005: 1754-1803."},{"key":"key\n\t\t\t\t20171013035730_REF31","doi-asserted-by":"crossref","unstructured":"Chamberlain MC, Kormanic PA. Prognostic significance of coexistent bulky metastatic central nervous system disease in patients with leptomeningeal metastases. Arch Neurol. 1997;54: 1364-1368.","DOI":"10.1001\/archneur.1997.00550230037013"},{"key":"key\n\t\t\t\t20171013035730_REF32","doi-asserted-by":"crossref","unstructured":"Bussani R, Cova M, Pozzi-Mucelli R, et al. Extensive metastatic leptomeningeal melanomatosis as the first clinical sign of a cutaneous melanoma: morphological correlations between magnetic resonance imaging and autopsy findings. A case report. Hum Pathol. 2003;34: 625-628.","DOI":"10.1016\/S0046-8177(03)00120-5"},{"key":"key\n\t\t\t\t20171013035730_REF33","doi-asserted-by":"crossref","unstructured":"Ahmann DL, Creagan ET, Hahn RG, et al. Complete responses and long term survivals after systemic chemotherapy for patients with advanced malignant melanoma. Cancer. 1989;63: 224.","DOI":"10.1002\/1097-0142(19890115)63:2<224::AID-CNCR2820630203>3.0.CO;2-I"},{"key":"key\n\t\t\t\t20171013035730_REF34","unstructured":"Anderson CM, Buzaid AC, Legha SS. Systemic treatments for advanced cutaneous melanoma. Oncology. 1995;95: 1149."},{"key":"key\n\t\t\t\t20171013035730_REF35","doi-asserted-by":"crossref","unstructured":"Sampson JH, Carter JH, Friedman AH, et al. Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg. 1998;88: 11-20.","DOI":"10.3171\/jns.1998.88.1.0011"},{"key":"key\n\t\t\t\t20171013035730_REF36","doi-asserted-by":"crossref","unstructured":"Manola J, Atkins M, Ibrahim J, et al. Prognostic factors in metastatic melanoma: a pooled analysis of Easter Cooperative Oncology Group trials. J Clin Oncol. 2000;8: 3782-3793.","DOI":"10.1200\/JCO.2000.18.22.3782"},{"key":"key\n\t\t\t\t20171013035730_REF37","doi-asserted-by":"crossref","unstructured":"Sirott MN, Wong GYC, Tao YT, et al. Prognostic factors in patients with metastatic melanoma. A multivariate analysis. Cancer. 1993; 72: 3091-3098.","DOI":"10.1002\/1097-0142(19931115)72:10<3091::AID-CNCR2820721034>3.0.CO;2-V"},{"key":"key\n\t\t\t\t20171013035730_REF38","unstructured":"Papadopoulos NE, Gerber DL, Eton O, et al. The role of intrathecal (IT) use of interleukin-2 (IL-2) in the treatment of leptomeningeal disease (LMD) in patients (pts) with melanoma [abstract]. Proc Annu Meet Am Soc Clin Oncol. 2002;21: A1408."},{"key":"key\n\t\t\t\t20171013035730_REF39","doi-asserted-by":"crossref","unstructured":"Balch CM. Soong SJ, Murad TM, et al. A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III). J Clin Oncol. 1983;1: 126-134.","DOI":"10.1200\/JCO.1983.1.2.126"},{"key":"key\n\t\t\t\t20171013035730_REF40","doi-asserted-by":"crossref","unstructured":"Meltzer PS. Genetic diversity in melanoma. N Engl J Med. 2005; 353: 2104-2107.","DOI":"10.1056\/NEJMp058173"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/10\/6\/1010\/13065468\/11_NO07-00153_Groves.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T04:14:44Z","timestamp":1507868084000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article\/10\/6\/1010\/1054917\/Prognostic-factors-and-outcomes-in-patients-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,1]]},"references-count":40,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2008,12,1]]},"published-print":{"date-parts":[[2008,12,1]]}},"URL":"https:\/\/doi.org\/10.1215\/15228517-2008-062","relation":{},"ISSN":["1523-5866","1522-8517"],"issn-type":[{"value":"1523-5866","type":"electronic"},{"value":"1522-8517","type":"print"}],"subject":[],"published-other":{"date-parts":[[2008,12]]},"published":{"date-parts":[[2008,12,1]]}}}